Washington quietly reversed course on one of the more consequential AI export restrictions of the year, and the beneficiary happens to be the one U.S. lab most aggressively courting overseas customers. Bloomberg senior strategist Neil Campling flagged the shift on July 1. He called it a green light for Anthropic’s global push at the exact moment Chinese frontier models have started closing the gap. The catch for stock pickers is that Anthropic is private, so the trade has to be built through the public names in its orbit.
The security fix that unlocked the door
At the heart of the reversal is Anthropic’s newest frontier model, Fable 5, which had been walled off from foreign users over national security concerns. Campling’s read is that the company patched the specific jailbreak pathway regulators cared about. “There’s extra security, some security safeguards in place now, which will get over the national security concerns that the government previously had,” he said, describing the fix as “putting a new safeguard to make sure that it targets and blocks behavior that had allowed some users to bypass the security before.” Restrictions on Anthropic’s Mythos model were eased on June 26, so this is the second loosening in a week.
Timing is the whole story. Chinese labs have been narrowing the frontier gap in recent weeks, and Dylan Patel has noted that Anthropic will reach 2-plus gigawatts of compute this year and roughly 10 gigawatts by the end of next year, a scale advantage that only matters if the company can actually sell into non-U.S. markets. Campling is blunt. “This should certainly enable Anthropic to continue its leadership that it has in the AI frontier space.”
Why Google DeepMind is suddenly playing catch-up
The more interesting piece of Campling’s commentary is about the science stack. Anthropic has been quietly building tools aimed at drug discovery and research workflows, which is the territory DeepMind has owned since AlphaFold. “DeepMind has gone from the leader and the most advanced model in this space to actually now playing catch up for the science industry,” Campling said.
That is a real problem for Alphabet (NASDAQ:GOOGL | GOOGL Price Prediction), whose entire enterprise pitch leans on DeepMind’s science leadership.
Alphabet is not exactly limping. Google Cloud is compounding revenue at 63% with a $462 billion backlog, and the company just replaced Verizon in the Dow Jones Industrial Average. But the regulatory ledger keeps growing.
A Swedish court just ordered Google to pay $1.97 billion in damages in the PriceRunner antitrust case, and reporting has surfaced that Google is tapping MediaTek to build its Triggerfish TPU, potentially at the expense of longtime partners. Losing the science narrative on top of that would sting.
The public tickers with Anthropic exposure
The cleanest way to get Anthropic exposure is through its infrastructure partners. Akamai Technologies (NASDAQ:AKAM) just landed a $1.8 billion, seven-year cloud infrastructure deal with Anthropic, and the stock surged 27% on the news. Akamai was a legacy CDN name six months ago. Now it is a diversification play for a lab that clearly does not want to be locked into any single hyperscaler.
Meanwhile, Meta Platforms (NASDAQ:META) is building its own AI cloud business to sell computing power and models, aimed squarely at AWS, Azure, and Google Cloud. The takeaway from Anthropic’s global clearance is that frontier AI is no longer a two-horse race between OpenAI and Google, and the cloud spend is going to fragment across more vendors than the market was pricing in a quarter ago.
What the reversal means for public shareholders
Anthropic staying private means you cannot buy it directly. What you can buy is the shift Campling is describing, where AI-for-science leaks away from DeepMind and international enterprise revenue leaks toward whichever U.S. lab regulators trust to ship abroad. Prediction markets already priced a low probability (0.122) that Trump would ease AI export controls to China, so this Anthropic-specific carve-out looks like the administration’s actual policy. That is to keep the wall up against Beijing and open the gate for U.S. labs with real safeguards.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks